Parkinson’s disease - Asia pacific – clinical Trial landscape

Due to the presence of half of the world’s aging population and a high population growth rate in APAC, the global burden of Parkinson's Disease is expected to rise, with China, Japan, and India collectively contributing to over a quarter of the cases.